CNR2 and glioblastoma: Importantly, GBM tumors express both major cannabinoid-specific receptors (CB1 and CB2), and the expression of these receptors has been detected in GBM cell lines, in ex vivo primary tumor cells from GBM patients, and in situ in GBM tissue biopsies.